5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.20▲ | 2.19▲ | 2.17▲ | 2.18▲ | 2.27▼ |
MA10 | 2.18▲ | 2.14▲ | 2.13▲ | 2.23▼ | 2.19▲ |
MA20 | 2.14▲ | 2.13▲ | 2.15▲ | 2.27▼ | 1.93▲ |
MA50 | 2.15▲ | 2.19▲ | 2.22▼ | 2.13▲ | 1.95▲ |
MA100 | 2.20▲ | 2.27▼ | 2.31▼ | 1.93▲ | 2.65▼ |
MA200 | 2.30▼ | 2.30▼ | 2.24▼ | 1.90▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.012▲ | 0.018▲ | 0.015▲ | -0.034▼ | 0.046▲ |
RSI | 63.168▲ | 58.600▲ | 54.322▲ | 49.655▼ | 55.258▲ |
STOCH | 96.667▲ | 94.297▲ | 85.700▲ | 21.261 | 51.673 |
WILL %R | -4.545▲ | -3.448▲ | -3.448▲ | -74.333 | -47.892 |
CCI | 82.774 | 120.853▲ | 154.201▲ | -91.314 | 31.510 |
Tuesday, July 01, 2025 01:36 AM
Creative Financial Designs Inc. ADV acquired a new stake in shares of IMAX Corporation (NYSE:IMAX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the ...
|
Friday, June 06, 2025 09:00 AM
Immix Biopharma, Inc. (IMMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
|
Thursday, June 05, 2025 03:17 PM
On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a price target of $7.00. The analyst based the rating on the promising ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 2.13 | 2.21 | 2.10 | 2.205 | 140,333 |
30/06/25 | 2.19 | 2.20 | 2.05 | 2.07 | 121,451 |
27/06/25 | 2.30 | 2.31 | 2.05 | 2.17 | 171,353 |
26/06/25 | 2.20 | 2.29 | 2.20 | 2.24 | 166,270 |
25/06/25 | 2.24 | 2.28 | 2.18 | 2.215 | 89,082 |
24/06/25 | 2.16 | 2.3023 | 2.16 | 2.24 | 58,160 |
23/06/25 | 2.2935 | 2.4289 | 2.17 | 2.23 | 130,387 |
20/06/25 | 2.40 | 2.4466 | 2.24 | 2.24 | 139,384 |
18/06/25 | 2.29 | 2.45 | 2.2008 | 2.39 | 193,988 |
17/06/25 | 2.41 | 2.4591 | 2.26 | 2.28 | 55,703 |
|
|
||||
|
|
||||
|
|